ArticleContemporary oncology (Poznan, Poland)2022

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients.

Lobna A Abdelaziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.